AP-L1898

· Suzhou Junjing BioSciences Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for AP-L1898, covering 2022-10-26 to 2022-10-26. Get the full timeline:

Most recent: Clinical Trial Update: AP-L1898 Capsule in Patients With Non-small Cell Lung Cancer [Phase 1, Phase 2]